Dengvaxia: What Healthcare Professionals Need to Know

At a glance

  • Dengvaxia, the first dengue vaccine, is a new option to prevent dengue infection.
  • Dengvaxia is unique because patients must have laboratory confirmation of a previous dengue infection before vaccination.
  • This learning activity will provide an overview of what healthcare professionals need to know.
Healthcare provider working on a computer.

Webinar

Low Resolution Video

About

Program description

This learning activity will provide an overview on eligibility criteria for the dengue vaccine, pre-vaccination screening recommendations, and vaccine storage, handling, and administration. Target audiences for this program include:

  • Physicians
  • Registered Nurses
  • Administrators
  • Advanced Practice Nurses
  • Certified Health Educators
  • DOs
  • Laboratorians
  • Licensed Practical/Vocational Nurses

Prerequisites

Participants should have a basic educational background in science including general knowledge in the subject areas of biology, immunization, and vaccine-preventable diseases.

Objectives

At the end of this course, participants will be able to:

  1. Describe the epidemiology and clinical manifestations of dengue.
  2. Describe dengue risk reduction and prevention measures.
  3. Identify areas where dengue is endemic.
  4. Describe indications for using the dengue vaccine in the United States.
  5. Explain required pre-vaccination screening and eligibility criteria for Dengvaxia.
  6. Identify Dengvaxia vaccine storage, handling, and administration.
  7. Describe the importance of interprofessional collaboration in public health settings when addressing dengue prevention.

Materials

  • Computer Hardware
  • Internet connection
  • Browser

This activity format is Web on Demand.

Accreditation

Accreditation statements

In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME

The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE

The Centers for Disease Control and Prevention designates this activity for 0.5 nursing contact hours.

CEU

The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.

CECH

Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 0.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0.5. Continuing Competency credits available are 0.5. CDC provider number 98614.

Obtaining Continuing Education (CE)

To receive continuing education (CE) for WD4550R Dengvaxia: What Healthcare Professionals Need To Know please visit CDC TRAIN and search for the course in the Course Catalog using WD4550R. Follow the steps below by March 17, 2026.

  1. Register for and complete the course.
  2. Pass the post-assessment at 80%.
  3. Complete the evaluation.
  4. Visit Your Learning to access your certificates and transcript.

FEES: No fees are charged for CDC's CE activities.

Credits and contacts

Credits: LCDR Joshua M. Wong, MD, EIS Officer, CDC Dengue Branch

Origination Date: March 17, 2022

Renewal Date: March 17, 2024

Expiration Date: March 17, 2026

Contact information: CDC, Dengue Branch, (787) 706-2399 dengue@cdc.gov

Disclosure

CDC, our planners, content experts and their spouses/partners wish to disclose they have no financial interests or other relationships with

  • The manufacturers of commercial products
  • Suppliers of commercial services
  • Ccommercial supporters.

Planners have reviewed content to ensure there is no bias.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial support for this continuing education activity.

Print
Content Source:
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)